[rev_slider_vc alias=”imaging”]

Microfluidics

With nearly 20 years of microfluidics experience, PerkinElmer continues to lead the industry in microfluidics technologies and innovations. Whether the research is focused on protein structure, genomic analysis, or compound screening, PerkinElmer has developed transforming instrumentation that leverage the benefits of microfluidics technology, improving data quality and accelerating the results.

 

 

Tissue Imaging

PerkinElmer‘s quantitative pathology and whole-slide imaging systems are ideal for the following areas of research:

  • Tissue biomarker discovery and validation
  • Signaling pathway analysis in cancer research and drug development
  • Microenvironment analysis, including assessment of tumor immunogenicity and immune cell phenotyping
  • Tissue cytometry, including multiplexed per-cell measures of nuclear, cytoplasmic, and membranous protein expression
  • Fluorescence whole slide scanning and tele-consultation
 

Multilabel Plate Readers

Antisel through PerkinElmer offers a wide range of plate readers to meet the diverse application requirements of any lab. From Absorbance and Luminescence / Fluorescence to Well imaging and Label Free Detection, each multimode plate reader features leading technologies, so no matter which instrument you choose, you can expect excellent performance for your specific applications.

 

High Content Screening Systems

PerkinElmer High Content Screening allows scientists to image more samples and analyze more parameters so that they can answer complex biological questions. The complete analysis capabilities, makes the systems suitable for a wide range of applications from basic research to assay development and screening.

Opera

Operreta

 

In Vivo Imaging & Analysis

Antisel through PerkinElmer offers a complete solution toolset for in vivo imaging. Our pre-clinical systems include 2D and 3D Fluorescence, Luminescence, Micro CT  and PET imaging technologies as well as the industry’s widest selection of imaging reagents.